Steel manufacturer Nucor Corporation (NYSE: NUE) has announced guidance for its third quarter ending September 28, 2024. The company is expected to release Q3 results on Monday, October 21, after markets close.
- The Nucor leadership said it expects third-quarter earnings to be in the range of $0.87 to $0.97 per share
- The EPS guidance includes estimated one-time non-cash pre-tax charges of about $123 million or $0.43 per share
- The management is looking for adjusted earnings in the range of $1.30 per share to $1.40 per share in Q3
- Earnings in the steel products segment are expected to decrease sequentially due to lower average selling prices and lower volumes
- Net income in the raw materials segment is also seen dropping in the third quarter compared to the second quarter of 2024
- During the third quarter, the company has repurchased around 2.5 million shares so far, at an average price of $156.07 per share
- It has returned about $2.29 billion to stockholders in the form of share repurchases and dividend payments year-to-date
- For the second quarter of 2024, Nucor reported net earnings of $2.68 per share; it posted net income of $4.57 per share for the third quarter of 2023
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Microsoft expected to report higher Q3 revenue, profit
Tech behemoth Microsoft Corp. (NASDAQ: MSFT) is preparing to report its third-quarter 2025 results, amid expectations for a year-over-year increase in revenue and earnings. The company has performed well recently,
What to expect when eBay (EBAY) reports its Q1 2025 earnings results
Shares of eBay Inc. (NASDAQ: EBAY) were down slightly in midday trade on Friday. The stock has gained 8% year-to-date. The ecommerce giant is slated to report its earnings results
AbbVie Q1 2025 adjusted earnings increase on 8% revenue growth; beat estimates
Biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) announced first-quarter 2025 financial results, reporting an increase in revenue and adjusted earnings. The company reported worldwide net revenues of $13.3 billion for the
